LIGAND PHARMACEUTICALS INCORPORATED (LGND) Gross margin 2016–2018
LIGAND PHARMACEUTICALS INCORPORATED (LGND) gross margin by fiscal year — reported gross profit divided by reported revenue.
97.5%FY2018 · since FY2016: 94.9% → 97.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | 97.5% | +1.3 pp |
| FY2017 | 96.2% | +1.3 pp |
| FY2016 | 94.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LGND financial trends
LGND RevenueLGND Net incomeLGND Net marginLGND Gross profitLGND Operating incomeLGND Operating marginLGND Operating cash flowLGND Free cash flowLGND Capital expendituresLGND Return on equityLGND Stock buybacksLGND Dividends paidLGND Total assetsLGND Total liabilitiesLGND Shareholders’ equityLGND overview →